Ovarian Cancer
Kluwer Academic Publishers
Published on 1. January 2002
Book
Hardback
XIII, 387 pages
978-0-7923-7530-2 (ISBN)
Article exhausted; check for reprint
Description
Ovarian carcinoma continues to be responsible for more deaths than all other gynecologic malignancies combined, due to a continued inability to achieve detection of early (rather than advanced) stage disease and the lack of effective tumor-specific therapeutics.
Ovarian carcinogenesis, invasion, and metastatic dissemination require a complex cascade of interrelated genetic, molecular, and biochemical events that regulate the neoplastic transition of normal ovarian surface epithelium.
This volume summarizes recent advances in ovarian cancer detection and treatment and provides an analysis of current research into aspects of malignant transformation, growth control, and metastasis. A more detailed understanding of these processes may ultimately translate into the development of novel approaches for the detection and control of ovarian cancer.
Ovarian carcinogenesis, invasion, and metastatic dissemination require a complex cascade of interrelated genetic, molecular, and biochemical events that regulate the neoplastic transition of normal ovarian surface epithelium.
This volume summarizes recent advances in ovarian cancer detection and treatment and provides an analysis of current research into aspects of malignant transformation, growth control, and metastasis. A more detailed understanding of these processes may ultimately translate into the development of novel approaches for the detection and control of ovarian cancer.
More details
Series
Language
English
Place of publication
New York
United States
Target group
College/higher education
Professional and scholarly
Illustrations
index
Dimensions
Height: 23.5 cm
Width: 15.5 cm
Weight
839 gr
ISBN-13
978-0-7923-7530-2 (9780792375302)
DOI
10.1007/978-1-4757-3587-1
Schweitzer Classification
Other editions
New editions

Book
10/2009
2nd Edition
Springer
€160.49
Shipment within 7-9 days
Content
Contributors. Foreword. I: Treatment. 1. The Scientific Basis of Early Detection of Epithelial Ovarian Cancer; D.A. Fishman, K. Bozorgi. 2. Risk Assessment and Genetic Testing; P.O. Chappuis, W.D. Foulkes. 3. Early Detection of Ovarian Cancer: Promise and Reality; R.C. Bast, Jr., et al. 4. Current Diagnosis and Treatment Modalities for Ovarian Cancer; P.E. Schwartz. 5. Ultrasound and Ovarian Cancer; L. Cohen, D.A. Fishman. 6. Gene Therapy; W.K. Huh, et al. II: Research. A: Malignant Transformation. 7. Normal Ovarian Surface Epithelium; A.S.T. Wong, N. Auersperg. 8. Cytopathology of the Ovary; D.V.S. DeFrias, et al. 9. Telomerase and Malignant Transformation; Jiamei Yu, L. Dubeau. 10. Homeobox Gene Expression in Ovarian Cancer; S.M. Pando, H.S. Taylor. B: Growth Control. 11. EGF/ErbB Receptor Family in Ovarian Cancer; N.J. Maihle, et al. 12. Critical Role of Lysophospholipids in the Pathophysiology, Diagnosis, and Management of Ovarian Cancer; G.B. Mills, et al. 13. Expression of CSF-1 and Its Receptor CSF-1R in Non-Hematopoietic Neoplasms; B. Kascinski. C: Cellular Regulation and Metastasis. 15. Adhesion Molecules; A.P.N. Skubitz. 16. Ovarian Cancer-Associated Proteinases; S. Ghosh, et al. 17. Angiogenesis and Metastasis; G.J. Sieczkiewicz, et al. Index.